Mattia Calissano | Director, Head of Pharmacovigilance
Orchard Therapeutics

Mattia Calissano is a seasoned pharmaceutical professional with extensive experience in pharmacovigilance. As theHead of Pharmacovigilance at Orchard Therapeutics, Mattia is responsible for overseeing the safety and risk management of the company's products. With a strong background in drug safety and regulatory compliance, he is dedicated to ensuring the highest standards of patient safety and product quality.

Mattia has a proven track record of successfully navigating complex regulatory landscapes and implementing robust pharmacovigilance strategies. He lead the safety strategy of a succesfull BLA, MA renewal in the EU and advised on the safety strategy for interaction with PMDA.

At the World Drug Safety Congress Europe 2025, Mattia will share his insights and expertise on addressing critical safety issues and advancing pharmacovigilance practices on rare diseases and ATMPs. 

With his in-depth knowledge and leadership in pharmacovigilance, Mattia is a trusted voice in the field and a driving force behind Orchard Therapeutics' commitment to patient safety and product excellence.